DNA & Genetics Qiagen Shares Rebound on Report It Is Assessing Strategic OptionsBy adminJanuary 25, 20260 Shares of Qiagen (NYSE: QGEN) this past week returned to trading in the $50 per-share range after three years mostly lumbering…
DNA & Genetics Agenus Closes Strategic Immunotherapeutic Collaboration with Zydus LifesciencesBy adminJanuary 15, 20260 Agenus closed its previously disclosed $141 million strategic collaboration with Zydus Lifesciences, which is designed to accelerate global development and…
DNA & Genetics Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital PCR IVD Oncology Kits in EuropeBy adminOctober 8, 20250 Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, and Gencurix,…
